Healthcare Business Rewind: Healthways POPS On Earnings, Streamline’s New DEAL
Shares of The Medicines Company (NASDAQ:MDCO) closed way up after its second quarter results handily beat estimates Wednesday morning. Total revenue jumped 13.5 percent year-over-year on lower selling, general and administrative costs and a rise in sales of Angiomax/Angiox international.
Don’t Miss: Celgene Second Quarter Earnings on the Horizon.
Healthways, Inc. (NASDAQ:HWAY) shares pop following a second quarter earnings beat of 15 cents exceeds consensus by 6 cents, and revenue moves up to $170.2 million, just above forecasts. Net profit drops to $5.06 million from $5.78 million. Earnings were driven by a sooner-than-expected recognition of performance-based fees, and the firm continues “to expect substantially stronger earnings” for the second half than for the first.
Shares of Streamline Health Solutions, Inc. (NASDAQ:STRM) gain a tenth of their value on the news that the firm has entered into a five-year, software as a service licensing contract with the worldwide business advisory firm, FTI Consulting, Inc. (NYSE:FCN). The new license quickly follows a recently reported joint marketing deal between the two firms.
Don’t Miss: Gilead Sciences Quarterly Earnings Near.
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.